The association of obesity on survival among patients with colorectal cancer (CRC) has not been well characterized. We investigated the association of prediagnostic body mass index (BMI)/waist-hip ratio (WHR) and total/cause-specific mortality in CRC patients. Our study included 1,452 patients who participated in two large cohort studies and were diagnosed with CRC during follow-up period. Participants were measured for anthropometrics and interviewed to collect relevant information at baseline, prior to any cancer diagnosis. Data on site-specific cancer incidence and cause-specific mortality were obtained via in-person surveys and annual record linkage with cancer and vital statistics registries. Cox proportional hazard models were used to evaluate the associations of BMI and WHR with survival. A total of 547 participants died during the follow-up period, including 499 who died of CRC. Relative to normal BMI (18.5 to <25.0 kg/m 2 ), obesity (BMI 30 kg/m 2 ) was associated with increased mortality resulting from all causes [hazard ratio (HR) 5 1.5, 95% confidence interval (CI): 1.1-2.1] and CRC (HR 5 1.5, 95% CI: 1.1-2.1). Elevated risk of death was also found among underweight patients (BMI < 18.5 kg/m 2 ), although not all risk estimates were statistically significant. Overweight BMI (25.0 to <30.0 kg/m 2 ) was not associated with risk of death among CRC patients, nor was WHR. In conclusion, prediagnostic BMI was associated with survival among CRC patients following a U-shape pattern; obesity was associated with high mortality after CRC diagnosis. These findings provide support for maintaining healthy weight to improve the survival of CRC patients.
that the association varies with tumor location, molecular subtype or cancer stage. 1, 7, 13, 15 Even fewer studies have assessed the association of WHR with CRC mortality, and some of these studies reported that abdominal obesity may better predict all-cause and colorectal cancer mortality than BMI. 6, 16 Most studies that evaluated the association of obesity with CRC prognosis were conducted in European descendants. The role of obesity on cancer survival has been less well studied among East Asians who, in general, have a lower prevalence of overall obesity but higher prevalence of central obesity compared to those of European descent. It has been reported that Asians may have a higher level of visceral fat than European descendants at the same BMI level and thus are more vulnerable to insulin resistance. 17 To date, only four studies have evaluated the possible influence of obesity on CRC survival among Asian populations. [18] [19] [20] [21] However, these previous Asian studies had small sample sizes, did not adjust for potential confounders and did not evaluate the association of central obesity with CRC survival. The aim of our study is to investigate the influence of prediagnosis BMI and WHR on all-cause and CRC-specific mortality using the resources of two large cohort studies, the Shanghai Women's Health Study (SWHS) and the Shanghai Men's Health Study (SMHS).
Material and Methods

Study cohort
The SWHS and the SMHS are two on-going, populationbased, prospective cohort studies, conducted in Shanghai, People's Republic of China. Details of the study designs and baseline questionnaires have been published previously. 22, 23 Briefly, women aged 40-70 years and men aged 40-74 years, who were permanent residents of the study communities, were approached for the study by trained interviewers. At baseline recruitment, anthropometric measurements (including weight, height and circumferences of waist and hips), information on socio-demographic characteristics, lifestyle factors and medical history were collected through in-person interviews. BMI was calculated as weight in kilograms divided by the square of height in meters. WHR was calculated as waist circumference divided by hip circumference.
The SWHS recruited 74,942 women from 1997 to 2000 (participation rate 92.7%), and the SMHS recruited 61,480 men from 2002 to 2006 (participation rate 74.0%). These two cohorts have been followed up through a combination of inperson surveys every 2-4 years and annual record linkage with the population-based Shanghai Cancer Registry and the Shanghai Vital Statistics Registry to identify incident cancer cases and cause-specific mortality, with nearly complete follow-up. Cancer cases were verified by home visits and review of medical records and pathological slides. Clinical information was obtained by review of medical charts. By December 31, 2013, 1,627 cohort members had been diagnosed with incident CRC. Fourteen patients were excluded because of missing information for anthropometric measurements. To reduce potential biases due to reverse causality, 161 subjects diagnosed within 2 years of follow-up were excluded. Of the remaining 1,452 eligible patients, 894 were diagnosed with colon cancer and 558 were diagnosed with rectal cancer. There were 573 men and 879 women with CRC in this analysis. On the average, BMI and WHR were assessed about 8 years before CRC diagnosis for the patients included in this analysis. The study was approved by the relevant institutional review boards for human research. Written, informed consent was obtained from all participants.
Statistical analysis
The primary endpoints were death from any cause and death from CRC after CRC diagnosis. BMI was categorized according to WHO criteria: underweight, <18.5 kg/m . WHR was categorized by sexspecific quartiles. The normal weight and lowest WHR were used as reference categories. Follow-up time began on the date of CRC diagnosis and ended on the date of death or December 31, 2013, whichever came first. Differences in socio-demographic characteristics and other risk factors by prediagnosis BMI and WHR categories were evaluated using a t-test for continuous variables and a v 2 test for categorical variables. The Kaplan-Meier method was used to estimate survival rates, and the log-rank test was performed to test the differences. Hazard ratios (HRs) and 95% confidence intervals (95% CIs) were calculated using Cox proportional hazards models to evaluate the associations of prediagnosis BMI and WHR with hazard of death after adjusting for potential confounders. The validity of the proportional hazards assumption was evaluated by creating multiplicative
What's new? How does obesity impact colorectal cancer survival? And does body type make a difference? These authors conducted the first cohort study in Asian patients to examine the relationship between prediagnosis obesity and CRC. Asians often have more waist-centered fat relative to Europeans with the same BMI, so our study looked at both BMI and waist-to-hip ratio and their association with survival. They found that both high and low BMI before diagnosis were associated with poorer survival; waist-to-hip ratio did not affect survival. Maintaining a healthy weight, they conclude, is key to survival for colorectal cancer patients.
interaction terms between both BMI and WHR and time and comparing Cox models with and without interaction terms using the likelihood ratio test. We identified potential confounders using prior knowledge regarding the association between factors (both lifestyle and clinical) that are potentially related to both BMI and survival, and the 10% change-in- Adjusting for treatment did not change the results appreciably and thus the final models did not adjust for treatment. We also examined the association for BMI and WHR continuously using restricted cubic spline models with five knots (i.e., 5th, 25th, 50th, 75th and 95th percentiles) for both allcause and CRC-specific mortality. 24 All analyses were performed using SAS, version 9.4 software (SAS Institute, Inc., Cary, NC), and all tests of statistical significance were set at p < 0.05 for two-sided analyses.
Results
The mean follow-up time was 3.4 years after diagnosis of CRC (median, 2.3 years; range, 2.01 days to 14.1 years). After 
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excluding patients who died in the first 2 years of follow-up, 547 deaths were documented, of which 499 were due to CRC. The distribution of socio-demographic and other characteristics across BMI and WHR measurements is shown in Table 1 . There were no meaningful differences across categories of BMI and WHR for smoke, doing exercise, family history of CRC, subsite of CRC, TNM stage or treatment. Underweight participants were more likely to be regular smokers, and obese participants were more likely to be older, less educated and had lower income. Compared to participants in the lowest category of WHR, participants with a high WHR were more likely to be older, less educated, had lower income and have severe comorbidity. Adjusted HRs for all-cause and CRC-specific mortality by selected demographic and clinical characteristics are shown in Table 2 . In addition to cancer stage, age at diagnosis, sex and income were associated with both all-cause and CRCspecific mortality. In Kaplan-Meier curves showing survival rates according to prediagnosis BMI, underweight and obese participants had higher CRC-specific (log-rank p < 0.001) and all-cause mortality (log-rank p < 0.001) (Fig. 1) .
No violation of the validity of the proportional hazards assumption was observed. Multivariable-adjusted HRs for allcause and CRC-specific mortality by prediagnosis BMI categories are shown in Table 3 . In men and women combined, prediagnosis obese BMI compared to normal BMI was associated with 54% higher risk of all-cause death and 51% higher risk of CRC-specific death. Underweight was also associated with an elevated mortality, although the HRs were not statistically significant likely due to a small sample size. No statistically significant increases in hazard of death were found in the overweight group. When BMI was considered as a continuous variable using restricted cubic splines, a nadir of the U-shaped association of BMI with all-cause mortality was observed at BMI of 20-25 kg/m 2 (p for non-linearity 5 0.0001; Fig. 2) . A similar pattern was observed for BMI and CRCspecific mortality (Supporting Information Fig. S2 ). When stratified by sex and subsite of CRC, the association between prediagnosis obese BMI and mortality was more pronounced for women (all-cause: HR 5 1.68, 95% CI: 1.16-2.44; CRC-specific: HR 5 1.63, 95% CI: 1.11-2.41) than men, and the HR for the association of underweight BMI with allcause mortality was significant only among patients diagnosed with rectal cancer (all-cause: HR 5 2.01, 95% CI: 1.05-3.84). However, neither test for interaction by sex or CRC subsite was statistically significant (p 0.70) ( Table 3) .
We also examined the association of prediagnosis obese BMI relative to normal BMI with CRC-specific mortality across the strata of other potential predictors of survival, including cancer stage, physical activity, income and smoking status (Fig. 3) . Because of a small number of events among female smokers (n 5 6), analyses among female smokers were not conducted. There was no evidence for significant effect measure modification by any of these variables (all p for heterogeneity >0.05). Additionally, we conducted survival analyses stratified by diagnosis within 8 years of follow-up and diagnosis after 8 years; however, the results were very similar in these two strata (all p heterogeneity >0.05; Fig. 3 ). No significant association was found between prediagnosis WHR and all-cause (highest relative to lowest WHR quartile: HR 5 0.94, 95% CI: 0.81-1.10) or CRC-specific mortality (highest relative to lowest WHR quartile: HR 5 0.94, 95% CI: 0.80-1.10) in multivariable-Cox regression analyses (Table 4) or the Kaplan-Meier survival analysis (all-cause: log-rank p 5 0.78; CRC-specific: log-rank p 5 0.71; Supporting Information Fig. S1 ). All p values for interaction by sex and CRC subsite were 0.18 or higher (Table 4) . Analyses using continuous variables also revealed no significant association of WHR with total and CRC-specific mortality (Supporting Information Figs. S3 and S4) . In stratified analyses, no evidence was found for potential effect modification on the association of WHR and CRC survival outcomes (all p heterogeneity >0.05; Supporting Information Fig. S5 ). 
Discussion
In these two prospective cohort studies, prediagnostic BMI was associated with survival among CRC patients following a U-shape pattern; both underweight and obesity determined prior to cancer diagnosis were associated with increased allcause and CRC-specific mortality compared to normal BMI, whereas no significant association was observed for overweight BMI (25-29.9 kg/m 2 ). No significant association was observed between WHR and mortality outcomes in our study.
Only a few studies investigated the association between prediagnosis BMI and CRC survival, and the results were not consistent, but generally, high BMI is associated with poor survival results. 7, 9, 11, 16, 25 Two recent works showed differences in association between BMI and CRC survival. Kocarnik et al. found that overweight (BMI 25.0-29.9) was associated with increased mortality among patients with Stage I disease, and decreased mortality among those with Stages II-IV disease. 13 Kroenke et al. observed that BMI measure at the time of cancer diagnosis was associated with CRC mortality in a nonlinear fashion, but compared to the BMI group of 18.5 to <23.0, a reduced mortality was found for each of higher BMI groups (23.0 to <25.0, 25.0 to <28.0 and 28.0 to <30.0).
14 Because BMI was measured at the time of cancer diagnosis, a potential bias due to reverse causation is a concern. In general, similar to our results, most previous Figure 3 . Adjusted hazard ratios for CRC-specific mortality between obese BMI and normal BMI stratified by stage, physical activity, income, smoke and different intervals between measurement and diagnosis. HRs: Adjusted by age at diagnosis, sex, income level, smoking status, comorbidity and TNM stage. NE 5 not estimated due to small number of events. * HRs and 95% CI for obese BMI compared to Normal BMI. European studies indicate a U-shaped pattern of association for the relation between BMI and mortality.
Only two studies to date have evaluated the association between prediagnosis WHR and the survival of patients with CRC, and both of them were conducted in European descendants. Fedirko et al. 6 used quintile of WHR cut off points to analyze the association between prediagnosis WHR and survival after colorectal cancer diagnosis, while Prizment et al. 16 adopted tertile of WHR as cut off points. Unlike our study, their results showed that higher WHR was associated with increased risk of death. 6, 16 However, in the stratified analysis by sex of Fedirko's results, the significant association 21 or even an improved overall survival 18 associated with overweight. All these previous studies had small sample sizes, limiting their ability to rigorously evaluate the association of BMI and mortality among CRC patients. The previous studies also used different BMI categories in the analysis, making a direct comparison of their results with ours difficult. Furthermore, these previous studies assessed BMI at diagnosis rather than prediagnostic BMI. Because of possible weight loss during the cancer development and progression in some patients, reverse causation could affect the validity of the study results.
When participants were stratified according to tumor location, we found that the BMI-mortality association did not differ between colon and rectal cancer. Although, in a similar cohort study of CRC with predominantly Europeandescent participants, prediagnosis obese BMI was associated with higher risk of all-cause mortality among participants with rectal cancer but not colon cancer. 9 However, in another study, both underweight and obese patients were at increased risk of colon cancer death, no association was observed for those with rectal cancer. 7 Although it remains unclear whether obesity exerts different impacts on the prognosis of colon cancer and rectal cancer, it has been suggested that obesity adds to the technical challenge of pelvic operations in both open and laparoscopic radical proctectomy. 26 Some studies have reported that obesity was associated with shorter disease-free survival, retrieval of fewer lymph nodes, longer operative times, lower rates of sphincter preservation, higher rates of postoperative complications and higher likelihood of local recurrence in patients with rectal cancer. 21, 27, 28 Except for increasing the risk of suboptimal treatment and complications, the underlying mechanisms by which obesity affects CRC prognosis are largely unclear. It has been shown that obesity is associated with insulin resistance and higher levels of circulating insulin, and insulin could enhance the bioactivity of IGF-I, which can promote cell proliferation and protect cancer cells from apoptosis. 29 Other pathophysiological and biological mechanisms have also been suggested to impact cancer mortality, including adipokines, obesity-related inflammatory markers, nuclear factor kappa beta system and oxidative stresses. 30 Furthermore, some studies have demonstrated that the adverse effect of obesity on patient survival was modified by specific gene expression. 31, 32 Some studies have also found that underweight BMI was associated with increased mortality compared to normal BMI, an association possibly reflecting underlying comorbidities that increased mortality. 7, 8 In addition, underweight participants were more likely to develop chemotherapy-related toxicities and complications, 33 compromising the effect of cancer treatment. The strengths of our study include a large sample size, a standardized assessment of anthropometrics, ability to adjust for a wide range of potential confounding variables, and the nearly complete follow-up on outcomes. Limitations to our study include a lack of data on post-diagnosis BMI/WHR information, treatment related complications and detailed cancer treatment data. Because men and women were recruited in somewhat different time periods, potential period effects should be considered when comparing the results between men and women. Although the prediagnosis BMI used in our study was measured at different times before diagnosis, results from our survival analyses stratified by different intervals between measurement and diagnosis were very similar.
In conclusion, our cohort study found that prediagnostic BMI was associated with survival among CRC patients following a U-shape pattern; obesity determined prior to cancer diagnosis was independently associated with poor prognosis for CRC patients, whereas no statistically significant associations were observed for WHR. These findings indicate the importance of maintaining a healthy weight which may help to potentially improve prognosis following a colorectal cancer diagnosis.
